Diagnostic Accuracy of Liquid Biopsy in Endometrial Cancer

Background: Liquid biopsy is a minimally invasive collection of a patient body fluid sample. In oncology, they offer several advantages compared to traditional tissue biopsies. However, the potential of this method in endometrial cancer (EC) remains poorly explored. We studied the utility of tumor e...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Marta Łukasiewicz, Krzysztof Pastuszak, Sylwia Łapińska-Szumczyk, Robert Różański, Sjors G. J. G. In ‘t Veld, Michał Bieńkowski, Tomasz Stokowy, Magdalena Ratajska, Myron G. Best, Thomas Würdinger, Anna J. Żaczek, Anna Supernat, Jacek Jassem
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/98e457b86fcb4a24a353e7b87bdcd118
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:98e457b86fcb4a24a353e7b87bdcd118
record_format dspace
spelling oai:doaj.org-article:98e457b86fcb4a24a353e7b87bdcd1182021-11-25T17:03:26ZDiagnostic Accuracy of Liquid Biopsy in Endometrial Cancer10.3390/cancers132257312072-6694https://doaj.org/article/98e457b86fcb4a24a353e7b87bdcd1182021-11-01T00:00:00Zhttps://www.mdpi.com/2072-6694/13/22/5731https://doaj.org/toc/2072-6694Background: Liquid biopsy is a minimally invasive collection of a patient body fluid sample. In oncology, they offer several advantages compared to traditional tissue biopsies. However, the potential of this method in endometrial cancer (EC) remains poorly explored. We studied the utility of tumor educated platelets (TEPs) and circulating tumor DNA (ctDNA) for preoperative EC diagnosis, including histology determination. Methods: TEPs from 295 subjects (53 EC patients, 38 patients with benign gynecologic conditions, and 204 healthy women) were RNA-sequenced. DNA sequencing data were obtained for 519 primary tumor tissues and 16 plasma samples. Artificial intelligence was applied to sample classification. Results: Platelet-dedicated classifier yielded AUC of 97.5% in the test set when discriminating between healthy subjects and cancer patients. However, the discrimination between endometrial cancer and benign gynecologic conditions was more challenging, with AUC of 84.1%. ctDNA-dedicated classifier discriminated primary tumor tissue samples with AUC of 96% and ctDNA blood samples with AUC of 69.8%. Conclusions: Liquid biopsies show potential in EC diagnosis. Both TEPs and ctDNA profiles coupled with artificial intelligence constitute a source of useful information. Further work involving more cases is warranted.Marta ŁukasiewiczKrzysztof PastuszakSylwia Łapińska-SzumczykRobert RóżańskiSjors G. J. G. In ‘t VeldMichał BieńkowskiTomasz StokowyMagdalena RatajskaMyron G. BestThomas WürdingerAnna J. ŻaczekAnna SupernatJacek JassemMDPI AGarticleendometrial cancertumor educated plateletscirculating tumor DNAmolecular markersliquid biopsyartificial intelligenceNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENCancers, Vol 13, Iss 5731, p 5731 (2021)
institution DOAJ
collection DOAJ
language EN
topic endometrial cancer
tumor educated platelets
circulating tumor DNA
molecular markers
liquid biopsy
artificial intelligence
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle endometrial cancer
tumor educated platelets
circulating tumor DNA
molecular markers
liquid biopsy
artificial intelligence
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Marta Łukasiewicz
Krzysztof Pastuszak
Sylwia Łapińska-Szumczyk
Robert Różański
Sjors G. J. G. In ‘t Veld
Michał Bieńkowski
Tomasz Stokowy
Magdalena Ratajska
Myron G. Best
Thomas Würdinger
Anna J. Żaczek
Anna Supernat
Jacek Jassem
Diagnostic Accuracy of Liquid Biopsy in Endometrial Cancer
description Background: Liquid biopsy is a minimally invasive collection of a patient body fluid sample. In oncology, they offer several advantages compared to traditional tissue biopsies. However, the potential of this method in endometrial cancer (EC) remains poorly explored. We studied the utility of tumor educated platelets (TEPs) and circulating tumor DNA (ctDNA) for preoperative EC diagnosis, including histology determination. Methods: TEPs from 295 subjects (53 EC patients, 38 patients with benign gynecologic conditions, and 204 healthy women) were RNA-sequenced. DNA sequencing data were obtained for 519 primary tumor tissues and 16 plasma samples. Artificial intelligence was applied to sample classification. Results: Platelet-dedicated classifier yielded AUC of 97.5% in the test set when discriminating between healthy subjects and cancer patients. However, the discrimination between endometrial cancer and benign gynecologic conditions was more challenging, with AUC of 84.1%. ctDNA-dedicated classifier discriminated primary tumor tissue samples with AUC of 96% and ctDNA blood samples with AUC of 69.8%. Conclusions: Liquid biopsies show potential in EC diagnosis. Both TEPs and ctDNA profiles coupled with artificial intelligence constitute a source of useful information. Further work involving more cases is warranted.
format article
author Marta Łukasiewicz
Krzysztof Pastuszak
Sylwia Łapińska-Szumczyk
Robert Różański
Sjors G. J. G. In ‘t Veld
Michał Bieńkowski
Tomasz Stokowy
Magdalena Ratajska
Myron G. Best
Thomas Würdinger
Anna J. Żaczek
Anna Supernat
Jacek Jassem
author_facet Marta Łukasiewicz
Krzysztof Pastuszak
Sylwia Łapińska-Szumczyk
Robert Różański
Sjors G. J. G. In ‘t Veld
Michał Bieńkowski
Tomasz Stokowy
Magdalena Ratajska
Myron G. Best
Thomas Würdinger
Anna J. Żaczek
Anna Supernat
Jacek Jassem
author_sort Marta Łukasiewicz
title Diagnostic Accuracy of Liquid Biopsy in Endometrial Cancer
title_short Diagnostic Accuracy of Liquid Biopsy in Endometrial Cancer
title_full Diagnostic Accuracy of Liquid Biopsy in Endometrial Cancer
title_fullStr Diagnostic Accuracy of Liquid Biopsy in Endometrial Cancer
title_full_unstemmed Diagnostic Accuracy of Liquid Biopsy in Endometrial Cancer
title_sort diagnostic accuracy of liquid biopsy in endometrial cancer
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/98e457b86fcb4a24a353e7b87bdcd118
work_keys_str_mv AT martałukasiewicz diagnosticaccuracyofliquidbiopsyinendometrialcancer
AT krzysztofpastuszak diagnosticaccuracyofliquidbiopsyinendometrialcancer
AT sylwiałapinskaszumczyk diagnosticaccuracyofliquidbiopsyinendometrialcancer
AT robertrozanski diagnosticaccuracyofliquidbiopsyinendometrialcancer
AT sjorsgjgintveld diagnosticaccuracyofliquidbiopsyinendometrialcancer
AT michałbienkowski diagnosticaccuracyofliquidbiopsyinendometrialcancer
AT tomaszstokowy diagnosticaccuracyofliquidbiopsyinendometrialcancer
AT magdalenaratajska diagnosticaccuracyofliquidbiopsyinendometrialcancer
AT myrongbest diagnosticaccuracyofliquidbiopsyinendometrialcancer
AT thomaswurdinger diagnosticaccuracyofliquidbiopsyinendometrialcancer
AT annajzaczek diagnosticaccuracyofliquidbiopsyinendometrialcancer
AT annasupernat diagnosticaccuracyofliquidbiopsyinendometrialcancer
AT jacekjassem diagnosticaccuracyofliquidbiopsyinendometrialcancer
_version_ 1718412791418716160